# Palonosetron Hydrochloride

NDC: 0703-4094
Generic name: Palonosetron Hydrochloride
Labeler / Manufacturer: Teva Parenteral Medicines, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180323
Marketing ended: 20261231
FDA application: ANDA090713

## Active ingredients

- PALONOSETRON HYDROCHLORIDE: .25 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0703-4094"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0703-4094
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=911783eb-91a8-4ef4-bd6f-809211e207d6